Dr. Reddy’s Hit With 483 for Supplier Quality Agreements, CAPA Issues

The FDA issued Dr. Reddy’s a Form 483 after an inspection of its Medak, Telengana facility in India determined it did not establish quality agreements with material suppliers and failed to complete multiple CAPAs in a timely manner, among other violations.
Source: Drug Industry Daily